Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2017, Article ID 4697194, 8 pages
https://doi.org/10.1155/2017/4697194
Research Article

Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre

1Institute for Liver and Digestive Health, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK
2Department of Gastroenterology and Hepatology, Guy’s and St Thomas’ Hospital, NHS Foundation Trust, Westminster Bridge Rd., London SE1 7EH, UK
3Department of Biological Sciences, University College London, Gower St., Bloomsbury, London WC1E 6BT, UK

Correspondence should be addressed to Paul Cordero; ku.ca.lcu@zehcnas.luap and Jude A. Oben; ku.ca.lcu@nebo.j

Received 19 October 2017; Revised 28 November 2017; Accepted 5 December 2017; Published 26 December 2017

Academic Editor: Branka Filipović

Copyright © 2017 Vi Nguyen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Bellentani, F. Scaglioni, M. Marino, and G. Bedogni, “Epidemiology of non-alcoholic fatty liver disease,” Digestive Diseases, vol. 28, no. 1, pp. 155–161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. R. Charlton, J. M. Burns, R. A. Pedersen, K. D. Watt, J. K. Heimbach, and R. A. Dierkhising, “Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States,” Gastroenterology, vol. 141, no. 4, pp. 1249–1253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Dietrich and C. Hellerbrand, “Non-alcoholic fatty liver disease, obesity and the metabolic syndrome,” Best Practice & Research Clinical Gastroenterology, vol. 28, no. 4, pp. 637–653, 2014. View at Publisher · View at Google Scholar
  4. J. L. Temple, P. Cordero, J. Li, V. Nguyen, and J. A. Oben, “A guide to non-alcoholic fatty liver disease in childhood and adolescence,” International Journal of Molecular Sciences, vol. 17, no. 6, article no. 947, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Cordero, P. Gonzalez-Muniesa, F. I. Milagro, J. Campion, and J. A. Martinez, “Perinatal maternal feeding with an energy dense diet and/or micronutrient mixture drives offspring fat distribution depending on the sex and growth stage,” Journal of Animal Physiology and Animal Nutrition, vol. 99, no. 5, pp. 834–840, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Cordero, J. Li, and J. A. Oben, “Epigenetics of obesity: beyond the genome sequence,” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 18, no. 4, pp. 361–366, 2015. View at Publisher · View at Google Scholar
  7. P. Manna and S. K. Jain, “Obesity, oxidative stress, adipose tissue dysfunction, and the associated health risks: causes and therapeutic strategies,” Metabolic Syndrome and Related Disorders, vol. 13, no. 10, pp. 423–444, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Ng, T. Fleming, M. Robinson, and et al, “Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 384, no. 9945, pp. 766–781, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Gonzalez-Muniesa, M. Mártinez-González, F. B. Hu et al., “Obesity,” Nature Reviews Disease Primers, vol. 3, p. 17034, 2017. View at Publisher · View at Google Scholar
  10. C. D. Williams, J. Stengel, M. I. Asike et al., “Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study,” Gastroenterology, vol. 140, no. 1, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ekstedt, L. E. Franzén, U. L. Mathiesen et al., “Long-term follow-up of patients with NAFLD and elevated liver enzymes,” Hepatology, vol. 44, no. 4, pp. 865–873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. L. White, F. Kanwal, and H. B. El-Serag, “Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review,” Clinical Gastroenterology and Hepatology, vol. 10, no. 12, pp. 1342.e2–1359.e2, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. A. Adams, J. F. Lymp, J. St. Sauver et al., “The natural history of nonalcoholic fatty liver disease: a population-based cohort study,” Gastroenterology, vol. 129, no. 1, pp. 113–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Lazo, R. Hernaez, S. Bonekamp et al., “Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study,” BMJ, vol. 343, no. 7836, Article ID d6891, p. 1245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Byrne, Z. Cooper, and C. Fairburn, “Weight maintenance and relapse in obesity: A qualitative study,” International Journal of Obesity, vol. 27, no. 8, pp. 955–962, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Phelan, J. O. Hill, W. Lang et al., “Recovery from relapse among successful weight maintainers,” American Journal of Clinical Nutrition, vol. 78, pp. 1079–1084, 2003. View at Google Scholar
  18. L. Sjoström, M. Peltonen, P. Jacobson et al., “Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications,” Journal of the American Medical Association, vol. 311, no. 22, pp. 2297–2304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Imaz, C. Martinez-Cervell, E. E. García-Álvarez, J. M. Sendra-Gutiérrez, and J. González-Enríquez, “Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis,” Obesity Surgery, vol. 18, no. 7, pp. 841–846, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Genco, T. Bruni, S. B. Doldi et al., “BioEnterics intragastric balloon: the Italian experience with 2,515 patients,” Obesity Surgery, vol. 15, no. 8, pp. 1161–1164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Folini, A. Veronelli, A. Benetti et al., “Liver steatosis (LS) evaluated through chemical-shift magnetic resonance imaging liver enzymes in morbid obesity; effect of weight loss obtained with intragastric balloon gastric banding,” Acta Diabetologica, vol. 51, no. 3, pp. 361–368, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Forlano, A. M. Ippolito, A. Iacobellis et al., “Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients,” Gastrointestinal Endoscopy, vol. 71, no. 6, pp. 927–933, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Li, P. Cordero, V. Nguyen, and J. A. Oben, “The role of vitamins in the pathogenesis of non-alcoholic fatty liver disease,” Integrative Medicine Insights, vol. 11, pp. 19–25, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. G. C. Nunes, D. Pajecki, M. E. de Melo, M. C. Mancini, R. de Cleva, and M. A. Santo, “Assessment of Weight Loss With the Intragastric Balloon in Patients With Different Degrees of Obesity,” Surgical Laparoscopy, Endoscopy & Percutaneous Techniques, vol. 27, no. 4, pp. e83–e86, 2017. View at Publisher · View at Google Scholar
  25. T. Karlas, D. Petroff, M. Sasso et al., “Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis,” Journal of Hepatology, vol. 66, no. 5, pp. 1022–1030, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Marfell-Jones, “Preface,” Kinanthropometry VIII: Proceedings of the 8th International Conference of the International Society for the Advancement of Kinanthropometry (ISAK), p. viii, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  28. K. V. Patel, J. Ooi, S. Ray, N. Griffin, and J. A. Oben, “Abdominal pain following obesity treatment,” Gut, vol. 63, no. 2, pp. 364-365, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Dee, K. Kearns, C. O'Neill et al., “The direct and indirect costs of both overweight and obesity: A systematic review,” BMC Research Notes, vol. 7, no. 1, article no. 242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Genco, G. López-Nava, C. Wahlen et al., “Multi-Centre european experience with intragastric balloon in overweight populations: 13 years of experience,” Obesity Surgery, vol. 23, no. 4, pp. 515–521, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Genco, M. Cipriano, V. Bacci et al., “BioEnterics® Intragastric Balloon (BIB®): A short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients,” International Journal of Obesity, vol. 30, no. 1, pp. 129–133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. E. M. H. Mathus-Vliegen and G. N. J. Tytgat, “Intragastric balloon for treatment-resistant obesity: Safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up,” Gastrointestinal Endoscopy, vol. 61, no. 1, pp. 19–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. E. M. Brunt, D. E. Kleiner, L. A. Wilson, P. Belt, and B. A. Neuschwander-Tetri, “Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings,” Hepatology, vol. 53, no. 3, pp. 810–820, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-M. Lee, H. C. Low, L. G. Lim et al., “Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: A pilot study,” Gastrointestinal Endoscopy, vol. 76, no. 4, pp. 756–760, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Genco, M. Cipriano, V. Bacci et al., “Intragastric balloon followed by diet vs intragastric balloon followed by another balloon: A prospective study on 100 patients,” Obesity Surgery, vol. 20, no. 11, pp. 1496–1500, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Genco, S. Balducci, V. Bacci et al., “Intragastric balloon or diet alone? A retrospective evaluation,” Obesity Surgery, vol. 18, no. 8, pp. 989–992, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Mitura and K. Garnysz, “In search of the ideal patient for the intragastric balloon - Short- and long-term results in 70 obese patients,” Wideochirurgia i Inne Techniki Maloinwazyjne, vol. 10, no. 4, pp. 541–547, 2015. View at Publisher · View at Google Scholar · View at Scopus